Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Biomarkers Market size was valued at US$ 45.1 billion in 2023 and is poised to grow at a significant CAGR of 12.2% from 2024-2030. Biomarkers are cellular or molecular diagnostic tools, measured in in biological samples, for instance, urine, stool and blood. It is utilized as an indicator to check and assess biological, pharmacological and pathogenic procedures. Biomarkers range from proteins, lipids, carbohydrates, RNA, DNA, hormones, platelets etc. Currently wide range of biomarkers are available for the different systems such as cardiovascular, metabolic system and immune system. Biomarkers not only help in diagnosis of the disease but also helps in tracking progression, regression and outcome after the intervention. Furthermore, biomarkers are also used in the drug development. Biomarkers of exposure and biomarkers of disease are the two major types of diagnostic biomarkers. Biomarkers of exposure are a new method for determining the quantity of harmful chemicals in a person's body.
These biomarkers allow for the detection of aberrant activity and the calculation of the pre-disease state. Biomarkers of disease are used to identify disease conditions and to help validate clinical trials for new drugs. A perfect biomarker has specific qualities, such as being safe and easy to assess, being cost-effective to follow up on, and being changeable with treatment that is consistent across gender and ethnic groups. Biomarkers are used to predict serious illnesses like diabetes and cardiovascular disease, as well as cancer, neurological disorders, immunological disorders, and others. Every biomarker shows if a disease or a state of health exists, and they can be combined to give a complete picture of how healthy a person is and whether a diagnosis is required. Biomarkers are also employed in imaging technologies to give clear imaging of cancer tumours and other issues, as well as in clinical trials to identify the effect and effects of medications early on.
Study Period
2024-2030Base Year
2023CAGR
12.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
biomarkers market primarily driven by rise in demand and need for the accurate diagnosis of disease and progression of the intervention due to the increase in diseases like cancer and cardiovascular diseases. In addition, initiatives taken by the government and market players in biomarker research coupled with increase in the number of clinical research organizations are expected to boost the market over the forecast period.
Furthermore, expansion of the applications of biomarkers in drug development and diagnostic segments projected to propel the growth of market in near future. On the other hand, high cost of discovery and development, poor reimbursement policies and technical issues in sample collection may hamper the market growth over the forecast period.
North America projected to have dominated market for biomarkers owing to the increase in ageing population and diagnosis of age related diseases.
Asia Pacific projected to have the lucrative opportunity of growth owing to the increase in the cardiovascular diseases and cancer cases. For instance, According to data of Ministry of Health, China, there were 203 million people are suffering from the cardiovascular diseases and is expected to increase 73% by 2030.
Furthermore, market players interest in expansion of their companies to Asia Pacific region due to low cost of production. This is likely to positively impact the growth of market in this region. Europe market expected to have the notable growth rate owing to the presence of the key market players and increase in the prevalence of diseases in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 45.1 billion |
|
Market CAGR |
12.2% |
|
By Type |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The biomarkers market size was valued at US$ 45.1 billion in 2023 and is poised to grow at a significant CAGR of 12.2% from 2024-2030.
The key players of biomarkers market are QIAGEN N.V. (Netherlands), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), Enzo, Biochem, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.)
Asia pacific is the fastest growing region in biomarkers market.
| 1.Executive Summary |
| 2.Global Biomarkers Market Introduction |
| 2.1.Global Biomarkers Market - Taxonomy |
| 2.2.Global Biomarkers Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Biomarkers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Biomarkers Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Biomarkers Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Biomarker of Disease |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Biomarker of Exposure |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Biomarkers Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Disease Diagnosis |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Disease Progression |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Drug Discovery and Development |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Development of Molecular Diagnostics |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Forensic |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Biomarkers Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Organizations |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Biomarkers Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Biomarkers Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Biomarker of Disease |
| 9.1.2.Biomarker of Exposure |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Disease Diagnosis |
| 9.2.2.Disease Progression |
| 9.2.3.Drug Discovery and Development |
| 9.2.4.Development of Molecular Diagnostics |
| 9.2.5.Forensic |
| 9.2.6.Others |
| 9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Research Organizations |
| 9.3.3.Diagnostic Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Biomarkers Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Biomarker of Disease |
| 10.1.2.Biomarker of Exposure |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Disease Diagnosis |
| 10.2.2.Disease Progression |
| 10.2.3.Drug Discovery and Development |
| 10.2.4.Development of Molecular Diagnostics |
| 10.2.5.Forensic |
| 10.2.6.Others |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Research Organizations |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Biomarkers Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Biomarker of Disease |
| 11.1.2.Biomarker of Exposure |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Disease Diagnosis |
| 11.2.2.Disease Progression |
| 11.2.3.Drug Discovery and Development |
| 11.2.4.Development of Molecular Diagnostics |
| 11.2.5.Forensic |
| 11.2.6.Others |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Research Organizations |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Biomarkers Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Biomarker of Disease |
| 12.1.2.Biomarker of Exposure |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Disease Diagnosis |
| 12.2.2.Disease Progression |
| 12.2.3.Drug Discovery and Development |
| 12.2.4.Development of Molecular Diagnostics |
| 12.2.5.Forensic |
| 12.2.6.Others |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Research Organizations |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Biomarkers Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Biomarker of Disease |
| 13.1.2.Biomarker of Exposure |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Disease Diagnosis |
| 13.2.2.Disease Progression |
| 13.2.3.Drug Discovery and Development |
| 13.2.4.Development of Molecular Diagnostics |
| 13.2.5.Forensic |
| 13.2.6.Others |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Research Organizations |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.QIAGEN N.V. (Netherlands) |
| 14.2.2.Merck Millipore (U.S.) |
| 14.2.3.PerkinElmer, Inc. (U.S.) |
| 14.2.4.Enzo Biochem, Inc. (U.S.) |
| 14.2.5.Bio-Rad Laboratories, Inc. (U.S.) |
| 14.2.6.Siemens Healthineers (Germany) |
| 14.2.7.Hoffmann-La Roche AG (Switzerland) |
| 14.2.8.Thermo Fisher Scientific, Inc. (U.S.) |
| 14.2.9.Abbott Laboratories (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.